FIZZ Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
FIZZ is not a good buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock is trading near short-term resistance, technical momentum is only moderately positive, and there is no strong proprietary buy signal. The business is stable and profitable, but revenue is slightly declining while analyst sentiment remains negative. Based on the full data set, the best direct call is to hold rather than buy aggressively today.
Pre-market price is 35.16, just above pivot at 34.531 and below the first resistance level at 35.406, so the stock is sitting close to near-term overhead resistance. MACD histogram is positive and expanding, which supports short-term upward momentum. RSI_6 at 70.682 is stretched near overbought territory, even if labeled neutral in the source. Moving averages are converging, which suggests the trend is not strongly established. Overall, the chart shows a mild bullish bias but not a compelling entry for a long-term beginner at this level.
The company remains profitable, with Q3 net income up 3.95% YoY, EPS up 4.76% YoY, and gross margin improving to 37.65%. The stock also has a mild short-term technical tailwind from positive MACD expansion. Options positioning is bullish overall with a low put-call open interest ratio. Similar candlestick pattern data suggests a modest positive drift over the next day, week, and month.
The stock is trading right around resistance, limiting immediate upside. No recent news, no recent congress trading activity, and no notable insider or hedge fund buying signals provide a fresh catalyst.
In the latest reported quarter, Q3 2026, National Beverage showed mixed but generally solid profitability trends. Revenue fell slightly to 264.586 million, down 0.92% YoY, but net income increased to 41.208 million, EPS rose to 0.44, and gross margin improved to 37.65%. This indicates better efficiency and earnings quality even though top-line growth remains weak.
Analyst sentiment is negative. UBS raised its price target to $35 from $34 on 2026-03-16 but kept a Sell rating. Earlier, on 2026-03-10, UBS lowered its target from $35 to $34 and also maintained a Sell rating. The trend in analyst opinion is not constructive, and Wall Street pros currently lean bearish overall on the stock.
